-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Hydroxyethylamine
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1418733-36-4.gif)
| Category | SARS-CoV |
| CAS | 1418733-36-4 |
| Description | Hydroxyethylamine (Compd VII) is a SARS-CoV-2 3CLpro inhibitor with an IC50 of ~10 μM in the spread assay. |
Product Information
| Synonyms | Ethanolamine|2-aminoethanol|monoethanolamine|colamine|Aminoethanol|Glycinol|Olamine|2-Hydroxyethylamine|Ethylolamine|2-Amino-1-ethanol|2-Hydroxyethanamine|2-Ethanolamine|beta-Hydroxyethylamine|2-Aminoethyl alcohol|beta-Aminoethanol|beta-Aminoethyl alcohol|1-Amino-2-hydroxyethane|beta-ethanolamine|Thiofaco M-50|2-Amino ethanol|Hydroxyethylamine|USAF EK-1597|Ethanolamine solution|UN 2491|c0594|MEA |
| Molecular Weight | 431.61 |
| Molecular Formula | C25H41N3O3 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Target | IC50: ~10 μM (SARS-CoV-2 3CLpro |
